// App-Quantinova.ai

631 : Predictors of Long-Term Retention of Methotrexate and Other Dmards with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry

Researchers

Presenter

  • Derek Haaland

Principal Investigators

  • Anna Jaroszynska

  • B Haraoui

  • Suneil Kapur

  • Jacqueline Stewart

  • Wojciech Olsynzynski

  • Keltie Anderson

  • Raman Rai

  • Michael Starr

  • Alexander Tsoukas

  • Eliofotisti Psaradellis

  • Emmanouil Rampakakis

  • Cathy Tkaczyk

  • Allen J Lehman

  • Francois Nantel

  • Brendan Osborne

Medical Centers

  • Rheumatology, Clinical Immunology & Allergy, McMaster University, Barrie, ON, Canada

  • Private Practice, Burlington, ON, Canada

  • Institut de Recherche en Rhumatologie de Montreal, Montreal, Canada

  • University of Ottawa, 139 Greenbank Rd, Suite 203, ON, Canada

  • Rheumatology, Penticton Regional Hospital, Penticton, BC, Canada,

  • University of Saskatchewan, Saskatoon, SK, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Private Practice, Burlington, ON, Canada

  • Rheumatology, McGill University, Pointe-Claire,, QC, Canada

  • Montreal University, Montreal, QC, Canada

  • JSS Medical Research, Montreal, QC, Canada

  • Medical Affairs, Janssen Inc., Toronto, ON, Canada

  • Janssen Inc., Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Ustekinumab

  • Infliximab

  • golimumab

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved